Sudarshan Pharma

{
  "main_header": {
    "sid": 1003813,
    "name": "Sudarshan Pharma",
    "stock_name": "Sudarshan Pharma",
    "full_name": "Sudarshan Pharma Industries Ltd",
    "name_url": "stocks-analysis/sudarshan-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.30",
    "chg": -1.7,
    "chgp": "-5.0%",
    "dir": -1,
    "prev_price": "34.00",
    "mcapval": "818.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 543828,
    "symbol": "",
    "ind_name": "Specialty Chemicals",
    "ind_code": 4,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE00TV01023",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "01:03 AM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": 244000,
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sudarshan-pharma-1003813-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sudarshan Pharma Falls 9.40%: Mixed Technicals and Debt Concerns Shape Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-falls-940-mixed-technicals-and-debt-concerns-shape-weekly-decline-4131350",
        "imagepath": "",
        "date": "2026-08-01 11:02:30",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Stock opens at ₹41.43, declines 0.93%</p>\n                    <p><strong>28 Jul:</strong> Sharp drop of 4.13% to ₹39.72 on low volume</p>\n                    <p><strong>29 Jul:</strong> Brief recovery with 1.76% gain to ₹40.42</p>\n                    <p><strong>30 Jul:</strong> Downgrade to Hold announced; stock falls 4.45%</p>\n                    <p><strong>31 Jul:</strong> Continued decline to ₹37.89, closing the week down 9.40%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.41.82</div></div>\n                    <div class=\"stat-item\"..."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-downgraded-to-hold-amid-mixed-technical-and-financial-signals-4129687",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_mojoScore_4129687.png",
        "date": "2026-07-31 08:19:26",
        "description": "Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating downgraded from Buy to Hold as of 30 July 2026. This adjustment reflects a nuanced shift across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust long-term growth and healthy financial performance, recent technical indicators and valuation metrics have moderated investor enthusiasm, prompting a more cautious stance."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Sees Technical Momentum Shift Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-sees-technical-momentum-shift-amid-mixed-signals-4129595",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_technicaldot_4129595.png",
        "date": "2026-07-31 08:02:58",
        "description": "Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a 4.45% decline in the latest trading session, the stock’s broader technical indicators present a nuanced picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-buy-4128429",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_mojoScore_4128429.png",
        "date": "2026-07-30 10:11:27",
        "description": "Sudarshan Pharma Industries Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 July 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 30 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sudarshan Pharma Industries Ltd to 52-Week High of Rs 42.16",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-hits-new-52-week-high-on-21-july-2026-4112798",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_priceRelatedfactors_4112798.png",
        "date": "2026-07-21 15:12:02",
        "description": "With a decisive surge to Rs 42.16 on 21 Jul 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, closing just 0.38% shy of this peak. This milestone caps a remarkable 47.55% rally over the past year, significantly outperforming the Sensex’s decline of 5.77% during the same period, underscoring the stock’s robust momentum amid a mixed broader market backdrop."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-is-rated-buy-4107901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_mojoScore_4107901.png",
        "date": "2026-07-19 10:10:27",
        "description": "Sudarshan Pharma Industries Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 July 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 19 July 2026, providing investors with the latest insights into its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Hits New 52-Week High of Rs 42.16 on Back of Strong Technical Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-hits-new-52-week-high-at-rs4216-4103438",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_priceRelatedfactors_4103438.png",
        "date": "2026-07-15 09:50:32",
        "description": "From a 52-week low of Rs 18.50 to a fresh high of Rs 42.16 on 15 Jul 2026, Sudarshan Pharma Industries Ltd has surged 128% in the past year, significantly outperforming the Sensex which declined 6.06% over the same period. This remarkable rally is underpinned by a confluence of bullish technical indicators and sustained price momentum, marking a notable milestone for the specialty chemicals micro-cap."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Sudarshan Pharma Industries Ltd to 52-Week High of Rs 41.4",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sudarshan-pharma-industries-ltd-hits-new-52-week-high-at-rs414-4098701",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_priceRelatedfactors_4098701.png",
        "date": "2026-07-13 15:07:14",
        "description": "With a decisive intraday surge to Rs 41.4 on 13 Jul 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a 39.11% gain over the past year and significantly outperforming the Sensex’s 5.87% decline during the same period."
      },
      {
        "title": "Sudarshan Pharma Industries Ltd Upgraded to Buy on Strong Technical and Financial Performance",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sudarshan-pharma-industries-ltd-upgraded-to-buy-on-strong-technical-and-financial-performance-4093073",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/SudarshanPharma_mojoScore_4093073.png",
        "date": "2026-07-08 08:33:45",
        "description": "Sudarshan Pharma Industries Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality assessments. The micro-cap specialty chemicals company has demonstrated robust operational growth, market-beating returns, and a bullish technical outlook, prompting this positive revision in its investment rating."
      }
    ],
    "total": 169,
    "sid": "1003813",
    "stock_news_url": "https://www.marketsmojo.com/news/sudarshan-pharma-industries-1003813"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026",
      "datetime": "09-Aug-2026",
      "details": "Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/June/2026.",
      "source": "BSE"
    },
    {
      "caption": "Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.",
      "datetime": "14-Jul-2026",
      "details": "The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 14 2026 for Hemal Vasantrai Mehta",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Jul-2026",
      "details": "Please find attached copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations 2018 received from Kfin Technologies Limited for the quarter ended 30/June/2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has declared <strong>3%</strong> dividend, ex-date: 25 Aug 23",
          "dt": "2023-08-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Sudarshan Pharma Industries Ltd has announced <strong>1:10</strong> stock split, ex-date: 22 Nov 24",
          "dt": "2024-11-22",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sudarshan Pharma Falls 9.40%: Mixed Technicals and Debt Concerns Shape Weekly Decline

2026-08-01 11:02:30

Key Events This Week

27 Jul: Stock opens at ₹41.43, declines 0.93%

28 Jul: Sharp drop of 4.13% to ₹39.72 on low volume

29 Jul: Brief recovery with 1.76% gain to ₹40.42

30 Jul: Downgrade to Hold announced; stock falls 4.45%

31 Jul: Continued decline to ₹37.89, closing the week down 9.40%

Week Open

Rs.41.82

Read full news article

Sudarshan Pharma Industries Ltd Downgraded to Hold Amid Mixed Technical and Financial Signals

2026-07-31 08:19:26

Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has seen its investment rating downgraded from Buy to Hold as of 30 July 2026. This adjustment reflects a nuanced shift across four key parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate robust long-term growth and healthy financial performance, recent technical indicators and valuation metrics have moderated investor enthusiasm, prompting a more cautious stance.

Read full news article

Sudarshan Pharma Industries Ltd Sees Technical Momentum Shift Amid Mixed Signals

2026-07-31 08:02:58

Sudarshan Pharma Industries Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a 4.45% decline in the latest trading session, the stock’s broader technical indicators present a nuanced picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Buy

2026-07-30 10:11:27

Sudarshan Pharma Industries Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 July 2026. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock’s current position as of 30 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Sudarshan Pharma Industries Ltd to 52-Week High of Rs 42.16

2026-07-21 15:12:02

With a decisive surge to Rs 42.16 on 21 Jul 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, closing just 0.38% shy of this peak. This milestone caps a remarkable 47.55% rally over the past year, significantly outperforming the Sensex’s decline of 5.77% during the same period, underscoring the stock’s robust momentum amid a mixed broader market backdrop.

Read full news article

Sudarshan Pharma Industries Ltd is Rated Buy

2026-07-19 10:10:27

Sudarshan Pharma Industries Ltd is rated Buy by MarketsMOJO, with this rating last updated on 07 July 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 19 July 2026, providing investors with the latest insights into its fundamentals, returns, and overall outlook.

Read full news article

Sudarshan Pharma Industries Ltd Hits New 52-Week High of Rs 42.16 on Back of Strong Technical Signals

2026-07-15 09:50:32

From a 52-week low of Rs 18.50 to a fresh high of Rs 42.16 on 15 Jul 2026, Sudarshan Pharma Industries Ltd has surged 128% in the past year, significantly outperforming the Sensex which declined 6.06% over the same period. This remarkable rally is underpinned by a confluence of bullish technical indicators and sustained price momentum, marking a notable milestone for the specialty chemicals micro-cap.

Read full news article

Broad-Based Technical Strength Lifts Sudarshan Pharma Industries Ltd to 52-Week High of Rs 41.4

2026-07-13 15:07:14

With a decisive intraday surge to Rs 41.4 on 13 Jul 2026, Sudarshan Pharma Industries Ltd has reached a fresh 52-week high, marking a 39.11% gain over the past year and significantly outperforming the Sensex’s 5.87% decline during the same period.

Read full news article

Sudarshan Pharma Industries Ltd Upgraded to Buy on Strong Technical and Financial Performance

2026-07-08 08:33:45

Sudarshan Pharma Industries Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, financial trends, valuation metrics, and overall quality assessments. The micro-cap specialty chemicals company has demonstrated robust operational growth, market-beating returns, and a bullish technical outlook, prompting this positive revision in its investment rating.

Read full news article

View All News